These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 11147718

  • 21. Long-term effectiveness and safety of GnRH agonist plus raloxifene administration in women with uterine leiomyomas.
    Palomba S, Orio F, Russo T, Falbo A, Cascella T, Doldo P, Nappi C, Lombardi G, Mastrantonio P, Zullo F.
    Hum Reprod; 2004 Jun; 19(6):1308-14. PubMed ID: 15117890
    [Abstract] [Full Text] [Related]

  • 22. Initiation of GnRH agonist treatment on 3-5 days postoperatively in endometriosis patients: a randomized controlled trial.
    Gong L, Zhang S, Han Y, Long Q, Zou S, Cao Y.
    J Clin Pharmacol; 2015 Aug; 55(8):848-53. PubMed ID: 25694383
    [Abstract] [Full Text] [Related]

  • 23. Aromatase inhibitors prevent the estrogen rise associated with the flare effect of gonadotropins in patients treated with GnRH agonists.
    Bedaiwy MA, Mousa NA, Casper RF.
    Fertil Steril; 2009 Apr; 91(4 Suppl):1574-7. PubMed ID: 18973892
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Treatment of uterine leiomyomas in perimenopausal women with gonadotropin-releasing hormone agonists.
    Nakamura Y, Yoshimura Y.
    Clin Obstet Gynecol; 1993 Sep; 36(3):660-7. PubMed ID: 8403612
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Preoperative treatment of uterine leiomyomas: clinical findings and expression of transforming growth factor-beta3 and connective tissue growth factor.
    De Falco M, Staibano S, D'Armiento FP, Mascolo M, Salvatore G, Busiello A, Carbone IF, Pollio F, Di Lieto A.
    J Soc Gynecol Investig; 2006 May; 13(4):297-303. PubMed ID: 16697947
    [Abstract] [Full Text] [Related]

  • 29. Beneficial effects of dienogest on uterine myoma volume: a retrospective controlled study comparing with gonadotropin-releasing hormone agonist.
    Ichigo S, Takagi H, Matsunami K, Suzuki N, Imai A.
    Arch Gynecol Obstet; 2011 Sep; 284(3):667-70. PubMed ID: 21052701
    [Abstract] [Full Text] [Related]

  • 30. Efficacy and safety investigation of Kuntai capsule for the add-back therapy of gonadotropin releasing hormone agonist administration to endometriosis patients: a randomized, double-blind, blank- and tibolone-controlled study.
    Chen JM, Gao HY, Ding Y, Yuan X, Wang Q, Li Q, Jiang GH.
    Chin Med J (Engl); 2015 Feb 20; 128(4):427-32. PubMed ID: 25673440
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: a prospective, randomized, double blind, placebo-controlled, crossover trial.
    Carr BR, Marshburn PB, Weatherall PT, Bradshaw KD, Breslau NA, Byrd W, Roark M, Steinkampf MP.
    J Clin Endocrinol Metab; 1993 May 20; 76(5):1217-23. PubMed ID: 8496313
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. GnRH agonists before surgery for uterine leiomyomas. A review.
    Crosignani PG, Vercellini P, Meschìa M, Oldani S, Bramante T.
    J Reprod Med; 1996 Jun 20; 41(6):415-21. PubMed ID: 8799917
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Toward removing uterine fibroids without surgery: subcutaneous infusion of a luteinizing hormone-releasing hormone agonist commencing in the luteal phase.
    Healy DL, Lawson SR, Abbott M, Baird DT, Fraser HM.
    J Clin Endocrinol Metab; 1986 Sep 20; 63(3):619-25. PubMed ID: 3090092
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Administration of nasal Buserelin as compared with subcutaneous Buserelin implant for endometriosis.
    Donnez J, Nisolle-Pochet M, Clerckx-Braun F, Sandow J, Casanas-Roux F.
    Fertil Steril; 1989 Jul 20; 52(1):27-30. PubMed ID: 2501110
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.